Thomas Englese - 14 Dec 2021 Form 4 Insider Report for AZIYO BIOLOGICS, INC. (ELUT)

Role
CHIEF COMMERCIAL OFFICER
Signature
/s/ Jeffrey Hamet, Attorney-in-Fact for Thomas Englese
Issuer symbol
ELUT
Transactions as of
14 Dec 2021
Net transactions value
+$27,938
Form type
4
Filing time
15 Dec 2021, 15:45:29 UTC
Next filing
10 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ELUT Class A Common Stock Purchase $27,938 +4,580 +902% $6.10 5,088 14 Dec 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 508 shares of Class A Common Stock acquired under the Company's 2020 Employee Stock Purchase Plan.